Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Current Assets (2016 - 2025)

Collegium Pharmaceutical has reported Current Assets over the past 10 years, most recently at $691.4 million for Q4 2025.

  • Quarterly results put Current Assets at $691.4 million for Q4 2025, up 43.37% from a year ago — trailing twelve months through Dec 2025 was $691.4 million (up 43.37% YoY), and the annual figure for FY2025 was $691.4 million, up 43.37%.
  • Current Assets for Q4 2025 was $691.4 million at Collegium Pharmaceutical, up from $613.9 million in the prior quarter.
  • Over the last five years, Current Assets for COLL hit a ceiling of $691.4 million in Q4 2025 and a floor of $296.3 million in Q1 2021.
  • Median Current Assets over the past 5 years was $490.3 million (2023), compared with a mean of $468.0 million.
  • Biggest five-year swings in Current Assets: fell 17.37% in 2024 and later soared 43.37% in 2025.
  • Collegium Pharmaceutical's Current Assets stood at $315.5 million in 2021, then surged by 33.1% to $420.0 million in 2022, then increased by 28.0% to $537.6 million in 2023, then decreased by 10.29% to $482.3 million in 2024, then surged by 43.37% to $691.4 million in 2025.
  • The last three reported values for Current Assets were $691.4 million (Q4 2025), $613.9 million (Q3 2025), and $549.2 million (Q2 2025) per Business Quant data.